Literature DB >> 699184

Distribution of cis-platin in blood.

R C Manaka, W Wolf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699184     DOI: 10.1016/0009-2797(78)90139-4

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


× No keyword cloud information.
  10 in total

1.  Determination of cis-diamminedichloroplatinum (II) in plasma proteins and hemoglobin of cancer patients.

Authors:  R Mustonen; P Hietanen; S Leppälä; M Takala; K Hemminki
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

Review 2.  Cisplatinum: a review, with special reference to cellular and molecular interactions.

Authors:  C L Litterst
Journal:  Agents Actions       Date:  1984-12

3.  [Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)].

Authors:  H W von Heyden; H Henkel; G A Nagel; N Weinstock
Journal:  Klin Wochenschr       Date:  1982-03-01

4.  Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.

Authors:  R Parti; W Wolf
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.

Authors:  J J Gullo; C L Litterst; P J Maguire; B I Sikic; D F Hoth; P V Woolley
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

6.  Extracorporeal cisplatin removal using direct hemoperfusion under hepatic venous isolation for hepatic arterial chemotherapy: an experimental study on pharmacokinetics.

Authors:  Y Maekawa; Y Ku; Y Saitoh
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity.

Authors:  J Uozumi; M Ishizawa; Y Iwamoto; T Baba
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

8.  The comparative tissues distribution of platinum and 14C in mice receiving 14C-labelled carboplatin.

Authors:  S E Dible; Z H Siddik; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

9.  The effect of cisplatin on renal ATPase activity in vivo and in vitro.

Authors:  J Uozumi; C L Litterst
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

10.  A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin.

Authors:  G J Veal; M J Griffin; E Price; A Parry; G S Dick; M A Little; S M Yule; B Morland; E J Estlin; J P Hale; A D Pearson; H Welbank; A V Boddy
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.